Stay updated on Avutometinib + Defactinib in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Avutometinib + Defactinib in Lung Cancer Clinical Trial page.

Latest updates to the Avutometinib + Defactinib in Lung Cancer Clinical Trial page
- Check3 days agoChange DetectedA site-wide notice announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.SummaryDifference1%

- Check10 days agoChange DetectedThe footer revision number changes from v3.7.1 to v3.7.2; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check17 days agoChange DetectedThe site footer revision identifier changes from v3.7.0 to v3.7.1 while the page remains a 403 error.SummaryDifference0.2%

- Check38 days agoChange DetectedThe page now shows a 403 Forbidden error with a minimal header and a Home button, indicating the study record is inaccessible; this replaces the previously visible study details and metadata.SummaryDifference18%

- Check59 days agoChange DetectedThe page shows a new revision tag v3.6.6 replacing the previous v3.6.5, indicating a minor backend or content-management update to the site. This change does not affect user-facing content.SummaryDifference0.0%

- Check80 days agoChange DetectedThe page's revision tag updated from v3.6.4 to v3.6.5, signaling a minor platform update. No user-facing content on the study page appears to have changed.SummaryDifference0.0%

Stay in the know with updates to Avutometinib + Defactinib in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avutometinib + Defactinib in Lung Cancer Clinical Trial page.